Korean J Schizophr Res.  2023 Apr;26(1):18-23. 10.16946/kjsr.2023.26.1.18.

Effects of Token Economy Intervention on Hospitalized Patients With Schizophrenia

• Kim SJ
• Seo YS
• Park KD
• Moon JJ
• Jeong JH
• Jung DU

• KMID: 2542196
• DOI: http://doi.org/10.16946/kjsr.2023.26.1.18

Abstract

Objectives
The purpose of this study was to investigate the effect of token economy intervention on the clinical characteristics and global function of patients with schizophrenia.
Methods
From June 1, 2022 to September 1, 2022, token economy intervention was conducted for hospitalized patients with schizophrenia in a mental hospital. Assessments were conducted before and after the intervention. Clinical Global Impression-Schizophrenia scale (CGI-SCH), Schizophrenia Quality of Life Scale (SQLS), Insight Scale for Psychosis (ISP), and Apathy Evaluation Scale (AES) were used to evaluate clinical characteristics. World Health Organization Disability Assessment Schedule (WHODAS) was used for global functional assessment.
Results
A total of 51 patients were included in the study. Through token economy intervention, depressive (p=0.001), cognitive symptom domain scores (p<0.001) in CGI-SCH, and SQLS score were significantly decreased (p=0.044). In the WHODAS evaluated by the clinician, the scores of self-care (p=0.012), life activities (p=0.006), and participation in society (p=0.040) decreased significantly.
Conclusion
It was confirmed that token economy intervention had a positive effect on depressive symptoms, cognitive symptoms, quality of life, self-care function, daily living function, and social participation function in hospitalized patients with schizophrenia.

Keyword

Schizophrenia; Psychiatric rehabilitation; Token economy; Quality of life; WHODAS; 삶의 질; 정신사회재활치료; 조현병; 토큰 경제 개입; WHODAS

Reference

1. Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001; 27:235–245.

2. Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry. 2005; 50:892–900.

3. Jang OJ, Lee BD, Chung YI. A Study on Factors Related to Long-term Hospitalization in Patients with Chronic Schizophrenia. J Korean Neuropsychiatr Assoc. 2015; 54:76–83.

4. Allardyce J, Boydell J. Review: the wider social environment and schizophrenia. Schizophr Bull. 2006; 32:592–598.

5. Morin L, Franck N. Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review. Front Psychiatry. 2017; 8:100.

6. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Schizophrenia Patient Outcomes Research T. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010; 36:94–103.

7. Ahn JS, Lee YD, Bang HS, Park JE, Shin JH. Efforts and Therapeutic Factors of Short-term Token Economy for Negative Symptoms of Schizophrenic In-patients. J Korean Neuropsychiatr Assoc. 1997; 36:794–803.

8. Dickerson FB, Tenhula WN, Green-Paden LD. The token economy for schizophrenia: review of the literature and recommendations for future research. Schizophr Res. 2005; 75:405–416.

9. Kim YM, Cho BM, Jang KY, Chung YI. A survey on the Long-term Hospitalized, Chronically Mentally-ill Patients in Mental Health Facilities. J Korean Neuropsychiatr Assoc. 1999; 38:774–783.

10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder: DSM-5. Washington, DC: American Psychiatric Association;2013.

11. Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010; 167:686–693.

12. Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl. 2003; 16–23.

13. Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean version of 4th revision of schizophrenia quality of life scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc. 2006; 45:401–410.

14. Markova IS, Roberts KH, Gallagher C, Boos H, McKenna PJ, Berrios GE. Assessment of insight in psychosis: a re-standardization of a new scale. Psychiatry Res. 2003; 119:81–88.

15. Kim J, Yim S, Yoon H. Assessing the reliability and validity of the korean version of the revised insight scale for psychosis (KISP). Korean J Schizophr Res. 2004; 7:15–22.

16. Lee YM, Park IH, Koo MS, Ko SY, Kang HM, Song JE. The Reliability and Validity of the Korean Version of Apathy Evaluation Scale and its Application in Patients with Schizophrenia. Korean J Schizophr Res. 2013; 16:80–85.

17. Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res. 2007; 90:186–197.

18. Elis O, Caponigro JM, Kring AM. Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. Clin Psychol Rev. 2013; 33:914–928.

19. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the korean version of the positive and negative syndrome scale. J Korean Neuropsychiatr Assoc. 2001; 40:1090–1105.

20. Puspitosari WA, Wardaningsih S, Nanwani S. Improving the quality of life of people with schizophrenia through community based rehabilitation in Yogyakarta Province, Indonesia: A quasi experimental study. Asian J Psychiatr. 2019; 42:67–73.

21. Lysaker PH, Vohs J, Hillis JD, Kukla M, Popolo R, Salvatore G, et al. Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Rev Neurother. 2013; 13:785–793.

22. Amador XF, Gorman JM. Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am. 1998; 21:27–42.

23. Sabbag S, Twamley EW, Vella L, Heaton RK, Patterson TL, Harvey PD. Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia. Schizophr Res. 2012; 137:190–195.